Trade with your broker
Market capitalisation, EUR | 204,842.72 m |
EPS, EUR | 7.96 |
P/B ratio | 4.54 |
P/E ratio | 11.40 |
Dividend yield | 3.25% |
Revenue, EUR | 42,031.24 m |
Net income, EUR | 7,925.26 m |
Profit margin | 18.86% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.44% | Equity United States Dividend | 215 | 0.70% | 7 | +17.38% | A2PZMV | IE00BKVKW020 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.41% | Equity World Social/Environmental Innovation | 368 | 0.60% | 4 | +11.47% | A3DHPA | IE000VTOHNZ0 |
L&G Pharma Breakthrough UCITS ETF | 2.53% | Equity World Health Care Innovation | 37 | 0.49% | 17 | +3.88% | A2H9XR | IE00BF0H7608 |
Broker | Rating | Order fee | Stock savings plans | |
---|---|---|---|---|
0.99€ | 1000 | View offer* | ||
1.00€ | 2500 | View offer* | ||
0.00€ | 2500 | View offer* | ||
0.00€ | 500 | View offer* | ||
0.00€ | 400 | View offer* |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
0.00€ | 0.00€ | View offer* | ||
0.00€ | 0.00€ | View offer* | ||
1.50€ 1.50% | 0.00€ | View offer* |
YTD | +3.85% |
1 month | -5.55% |
3 months | -9.79% |
6 months | -3.96% |
1 year | +5.35% |
3 years | +23.37% |
5 years | - |
Since inception (MAX) | +19.62% |
2023 | +6.31% |
2022 | +10.31% |
2021 | - |
2020 | - |
Volatility 1 year | 16.07% |
Volatility 3 years | 18.05% |
Volatility 5 years | - |
Return per risk 1 year | 0.33 |
Return per risk 3 years | 0.40 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -14.78% |
Maximum drawdown 3 years | -14.78% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -14.78% |